IFA Current Information

Here you’ll be informed about notifications and get to read excerpt from our letter to the suppliers:

11/17/2021 | Amendment to the Pharmaceutical Price Ordinance as of 15.12.2021

"... The Arzneimittelpreisverordnung changes on 15th December 2021 for prescription-only medicinal products.
Because of a 0.20 Euro fee for additional pharmaceutical services the calculation of the Apothekenverkaufspreis (AVP) changes as follows:

Abgabepreis des pharmazeutischen Unternehmers (APU)
+ 3.15 percent (max. 37.80 Euro)
+ 0.70 Euro
= Apothekeneinkaufspreis (AEP)

AEP
+ 3 percent
+ 8.56 Euro
+ 0.20 Euro (fee for additional pharmaceutical serivces)
+ VAT
= AVP

The attached excel EAD file contains your company’s affected prescription-only medicinal products with the new AVPs from 15.12.2021. If you consider it is necessary to correct the prices reported, please send us the corrected list by Friday, 26.11.2021 to ead@ifaffm.de exclusively. Thank you in advance.

In case of any further questions, please contact:

Ms. Ibtissame Charrai
E-Mail: Ibtissame.Charrai@ifaffm.de
Phone: +49 69 979919-53 ..."

less

11/08/2021 | Pre-notification: Pharmaceutical Price Ordinance on 15.12.2021

"... As of 15.12.2021, the Arzneimittelpreisverordnung (Pharmaceutical Price Ordinance) for prescription-only medicinal products will change. To finance additional pharmaceutical services, the fixed supplement on the pharmacy purchase price (AEP) will be increased by 0.20 euros. This means that all pharmacy retail prices (AVP) will have to be recalculated from 15.12.2021 for every medicines subject to taxation.

On Wednesdays, 17.11.2021 you will receive an electronic order file (EAD) with your product range file. In this file, the pharmacy sales prices of your medicinal products subject to tax will be calculated by us - free of charge for you - on the basis of the APU and will contain the AVP valid in the future.

If you wish to report changes to these prices, please return the amended file to us at ead@ifaffm.de by Friday 26.11.2021 at the latest.

In case of any further questions, please contact: 

Ms. Ibtissame Charrai
E-Mail: ibtissame.charrai@ifaffm.de
Phone: +49 69 979919-53

Thank you in advance for checking and updating your data at short notice. ..."

less

08/31/2021 | Update of the IFA information services on 1st October 2021

"... The following address information will no longer be maintained in the IFA database as of the publication date 1st October 2021:

  • Telephone 3 to Telephone 10
  • Telephone service section 1 to telephone service section 10
  • Fax Service section 1 to Fax Service section 2
  • E-mail address 3 to E-mail address 10
  • E-mail address Service area 1 to E-mail address Service area 10

Our updated file of orders and form D1 for address data (Auftragstabelle D1 – Supplier Address Data and Anlage D1 – Supplier Address Data) can be found on our website at First publication and change in address data.

If you have any questions, please do not hesitate to ask the following contact person:

Ibtissame Charrai
E-Mail: ibtissame.charrai@ifaffm.de ..."

less

07/05/2021 | IFA Specification UDI 2.0

"... We would like to inform you about the attached version 2.0 of the IFA Coding Specification UDI. The IFA Coding Specification UDI laid the foundation for the successful implementation of UDI requirements. Since then, numerous customer inquiries were received in connection with UDI. An exchange with the new customer groups revealed that IFA Coding is used for medical devices and medical device software distributed throughout Europe in practices, hospitals, laboratories as well as in the German pharmacy market. Providing the best possible support to IFA Coding users while at the same time ensuring interoperability for all actors in healthcare remain at the forefront of IFA’s activities. IFA has carried out an intensive review of the new requirements and incorporated particularly the following features in the update of the IFA Coding Specification UDI: 

  • For the different market segments, the suitable services of IFA were clarified.
  • A packaging level index has been added to the HPC. This allows multiple UDI-DI to be generated with one item reference as well as package sizes to be implemented in a UDI-DI.
  • Direct part marking specifications have been introduced as the MDR requires this for certain products such as surgical instruments.
  • New examples for the implementation of UDI requirements were included, such as for software. 

With the update of the IFA Coding Specification UDI, IFA supports actors in healthcare to keep in line with expanding legal requirements.

Should there be any question please feel free to contact the following contact person:

Axel Röpke
Email: axel.roepke@ifaffm.de
Phone: +49 69 979919-27"

less

04/16/2021 | Check of the medical devices classes

"... As known, Regulation (EU) 2017/745 (MDR) will be effective from 26th May 2021. In addition to a large number of changes resulting from this date of application, we would like to emphasise the obligation arising from Art. 123 Para. 3 Subpara. f) MDR. According to this, manufacturers of implantable medical devices and class III medical devices are obliged to provide such devices with a UDI code from 26th May 2021.

The correct reporting of the medical device class is therefore of particular importance for the trade levels. Please check whether your implants/medical devices of class III in particular have been reported correctly.

You’ll find attached a range data chart of your current listed medical devices, except for medical device class I. Class I medical devices are not listed, as they are not affected by the change. We kindly ask you to check the affected products. If changes are necessary, please fill them in the EAD-file and send it back to us only to ead@ifaffm.de.

Changes, which are send via EAD-file until the 22nd April 2021 are free of charge and will be confirmed with an order confirmation. As far as you are capable to check only a part of your range data chart during this time, you have the opportunity to send those partly checked requests.

As long as your product data are completely and correctly, there is no action required.

Should there be any question please feel free to contact the following contact persons:

Ibtissame Charrai
E-Mail: ibtissame.charrai@ifaffm.de
Phone: +49 69 979919-53

Claudia Niemeyer
E-Mail: claudia.niemeyer@ifaffm.de
Phone: +49 69 979919-31

We thank you in advance for your assessment and update of your data. ..."

less

03/18/2021 | Verification of the data on the calculation of the generic disc.

"... In response to market feedbacks, we would like to ask you to pay particular attention to the information on the calculation of the generic discount for your listed medicinal products and to check and, if necessary, to update this information. The discount according to § 130a para. 3b SGB V is determined on the basis of the data fields:

  • Unterlagenschutz (Data Exclusivity)
  • Wirkstoffpatent (Patented Active Substance)
  • Biologisches Arzneimittel (Biological medicinal product)
  • Solitär (Solitaire)

The legally regulated discount does not apply, if one of these data fields is set to yes. An incorrect entry will lead to an incorrect calculation of the discount. Further information can be found in Leitfaden zur Definition des Generikaabschlags nach § 130a Abs. 3b SGB V (the guideline on the definition of the generic discount according to § 130a para. 3b SGB V)

You’ll find attached a range data chart of your current listed medicinal products. We kindly ask you to check those data and to use the EAD-file, if the current information needs to be completed or corrected.

Changes, which are send via EAD-file, until the 23rd March 2021 are free of charge and will be confirmed with an order confirmation. As far as you are capable to check only a part of your range data chart during this time, you have the opportunity to send those partly checked requests.

As long as your product and address data are completely and correctly, there is no action required.

Should there be any question please feel free to contact the following contact persons:

Ms. Ibtissame Charrai
Email: ibtissame.charrai@ifaffm.de
Phone: +49 69 979919-53

Ms. Kamila Oke
Email: kamila.oke@ifaffm.de
Phone: +49 69 979919-24

We thank you in advance for your assessment and update of your data. ..."

less

12/22/2020 | Medical devices: Information on medical device class required

"... The Regulation (EU) 2017/745 on medical devices (MDR) and Regulation (EU) 2017/746 on in vitro diagnostic medical devices (IVDR) establish a system for the worldwide unique identification of medical devices. It is based on UDI (Unique Device Identification), the generic term for a unique product identifier consisting of UDI-DI and UDI-PI, as well as the Basic UDI-DI as the primary identifier of a device model.

From the date of MDR’s application on 26. May 2021 for every medical device falling under the MDR a UDI-DI must be assigned. For in-vitro diagnostics, the date of application of the regulation (EU) 2017/746 for in-vitro diagnostics from 05.04.2017 (IVDR) is on 26.05.2022.

In addition, depending on the class of the medical device, medical devices must be labelled with the UDI within 1 to 5 years after 26 May 2020 (Art. 123 para. 3 lit. f) MDR).

We do not yet have any information on the medical device class or in-vitro diagnostics class for the medical devices in your range of products listed in the attachment.

To enable your trading partners to meet the legal requirements for handling your products, we would ask you to add the missing information in the attached file.

Please return your additions to ead@ifaffm.de by Wednesday, 13.01.2021 at the latest.

Further information on the UDI can be found at: https://www.ifaffm.de/de/ifa-codingsystem/udi.html.

For any other questions, the following contact persons are at your disposal:

Charrai Ibtissame
Email: ibtissame.charrai@ifaffm.de
Phone: +49 69 979919-53

Carsten Schölles
Email: carsten.schoelles@ifaffm.de
Phone: +49 69 979919-51

We thank you in advance for checking and updating your data. ..."

less

11/30/2020 | VAT increase on 1st January 2021

"... At the turn of the year 2020/2021, the German legislator will repatriate the VAT to the values valid as of 30th June 2020, namely from 1st January 2021 the full VAT rate from 16 % to 19 % and the reduced VAT rate from 5 % to 7 %.

As a result, all pharmacy retail prices (AVP) for price-controlled medicinal products must be calculated including 19 % VAT as from 1st January 2021.

We would like to support you with the upcoming price changes due to value added tax.

Enclosed you will find an electronic order file (EAD) with your product range file. In this file, the pharmacy retail prices of your price-controlled pharmaceuticals as of publication status January 1st 2021 have been calculated by us – free of charge - on the basis of the APU, including now 19 % VAT.

The pharmacy retail prices of the non- price-controlled articles remain unchanged, as these are recommended prices of the supplier. However, from 1st January 2021 they will also include 19 % and 7 % value added tax.
 
If you seek to receive further price changes on 1st January 2021, please update the file and send us your notification as soon as possible, but no later than Monday 7th December 2020, to ead@ifaffm.de.

For this date, we expect an extraordinary amount of notifications that must be processed within a very short time. Therefore it is imperative that you send us your notification in good time.

The following contact persons are at your disposal for any questions you may have:

Benjamin Böttinger
Email: benjamin.boettinger@ifaffm.de
Phone: +49 69 979919-49
 
Carsten Schölles
Email: carsten.schoelles@ifaffm.de
Phone: +49 69 979919-51

We thank you in advance for checking and, if necessary, updating your data at short notice. ..."

less

11/16/2020 | Pre-notification: VAT increase on 1st January 2021

"... at the turn of the year 2020/2021, the German legislator will repatriate the VAT to the values valid as of 30th June 2020, namely from 1st January 2021 the full VAT rate from 16 % to 19 % and the reduced VAT rate from 5 % to 7 %.

As a result, all pharmacy retail prices (AVP) for price-controlled medicinal products must be calculated including 19 % VAT as from 1st January 2021.

We would like to support you with the upcoming price changes due to value added tax.
 
You will receive an electronic order file (EAD) with your product range file by 30th November 2020. This file will contain the pharmacy sales prices of your price-controlled pharmaceuticals with publication status as of 1st January 2021 calculated by us – free of charge - on the basis of the APU including the 19 % VAT which will in future apply.

The pharmacy retail prices of the non- price-controlled articles are unchanged, as these are recommended prices of the supplier. However, as from 1st January 2021 they will also include 19 % and 7 % value added tax. If you wish to change the UVP (recommended retail price), we await your change order.
 
The following contact persons are at your disposal for any questions you may have:

Benjamin Böttinger
Email: benjamin.boettinger@ifaffm.de
Phone: +49 69 979919-49
 
Carsten Schölles
Email: carsten.schoelles@ifaffm.de
Phone: +49 69 979919-51

We thank you in advance for checking and, if necessary, updating your data at short notice. ..."

less

10/01/2020 | Extension of the IFA Pharmaceutical Forms on 1st October 2020

"... due to applications to extend the IFA pharmaceutical form, IFA GmbH has expanded the IFA pharmaceutical form table as of 1st October 2020. The extension of the pharmaceutical form table may lead to changes in article-identifying characteristics with possible effects on the reference price allocations or aut idem. Therefore, the extension is made in accordance with a procedure agreed with the expert groups, with a lead time before the first publication.

If you carry medicinal products in your range, you are obliged to report the pharmaceutical form in line with section 3 of the SPC according to § 131 paragraph 4 SGB V (German Social Code Book 5).

The following new pharmaceutical forms are available since 1st October 2020 for first publication on 1st October 2021:

  • Konzentrat zur Herstellung einer Infusionsdispersion (KID)
    Concentrate for preparing an infusion dispersion

  • Pulver und Lösungsmittel zur Herstellung einer Injektionssuspension (PLS)
    Powder and solvent for suspension for injection

  • Sublingualspray, Lösung (SUL)
    Sublingual spray, solution

If any corrections need to be made in the data field pharmaceutical form in connection with the current pharmaceutical form extension, please let us know. With correct data notification, you make a significant contribution to ensure that data users can properly dispense and invoice your products.

Please use the Auftragstabelle für Änderungen an IFA-Darreichungsformen and send it to us in the case of changes to pharmaceutical data with the current SPC. In this exceptional case, we will process your notification free of charge until the specified publication date while maintaining the PZN. After a successful assessment we will change the pharmaceutical form and publish it for the first time on 01.10.2021.

The e-mail address for your change notifications is ifa@ifaffm.de.

Our website holds the Auftragstabelle für Änderungen an IFA-Darreichungsformen and Richtlinie zu den IFA-Darreichungsformen ready for you.

Mr Axel Röpke will be pleased to answer any questions you may have:

Email: axel.roepke@ifaffm.de
Phone: +49 69 979919-27 ..."

less

06/10/2020 | Reduction of VAT on 1st July 2020

"... as part of the measures to stimulate the economy, the Federal Government will reduce the full value added tax from 19 % to 16 % and the reduced value added tax rate from 7 % to 5 % for the period 1st July to 31st December 2020. For taxable drugs this means, that all pharmacy retail prices (AVP) must be calculated including 16 % VAT from 1st July 2020.

We would like to support you with the upcoming price changes due to value added tax.
 
Enclosed you will find an electronic order file (EAD) with your product range file. The pharmacy sales prices of your taxable pharmaceuticals with publication status as of 1st July 2020 have been calculated by us on the basis of the APU and now include 16 % VAT, in this file.
 
The pharmacy retail prices of the non-taxable articles are unchanged, as these are recommended prices of the supplier. However, from 1st July 2020 they will also include 16 % and 5 % value added tax.
 
If you wish to receive further price changes on 1st July 2020, please update the file and send us your notification as soon as possible, but no later than Friday 12th June 2020, to ead@ifaffm.de.
 
At this date, we expect an extraordinary number of notifications that must be processed within a very short time. Therefore it is imperative that you send us your report in good time.

The following contact persons are at your disposal for any questions you may have:

Benjamin Böttinger
Email: benjamin.boettinger@ifaffm.de
Phone: +49 69 979919-49
 
Carsten Schölles
Email: carsten.schoelles@ifaffm.de
Phone: +49 69 979919-51 ..."

less

Document Finder
Table of content
×